Abstract
The aims of this study were to define the specific parameters of the ATP chemosensitivity assay which most accurately predict a patient's clinical response to chemotherapeutic agents in epithelial ovarian cancer and to assess the clinical utility of the ATP assay. In our laboratory from 1992 to 1994, fresh tumor specimens from patients with epithelial ovarian carcinomas were assayed with the ATP chemosensitivity assay (ATP-CSA) for their in vitro responses to several chemotherapeutic agents including cisplatin, paclitaxel, and cyclophosphamide. Clinical data on 161 of those patients including all follow-up assessments were then collected, and an investigator blinded to the in vitro assay results determined the patients' responses to chemotherapy. In order to determine which parameter of the assay was the best predictor of clinical response for each drug, receiver-operator characteristic (ROC) curves were constructed for several parameters, including the amount of cell kill at particular dosage levels of drug, the slope of the dose-response curve, and the IC50, or the average concentration of drug at which 50% of the cells were nonviable. The specific parameter of the ATP-CSA which was most predictive of clinical response differ...Continue Reading
References
Jul 29, 1977·Science·A W Hamburger, S E Salmon
Jan 1, 1991·Cancer Investigation·L A LeoneB Rotman
Jan 1, 1991·Cancer·D D Von HoffR J Belt
Apr 4, 1990·Journal of the National Cancer Institute·D H Kern, L M Weisenthal
Jan 17, 1990·Journal of the National Cancer Institute·D D Von HoffF M Muggia
Nov 1, 1988·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·B RotmanJ P Cozzolino
Sep 1, 1988·Gynecologic Oncology·B U SevinH E Averette
Jul 1, 1987·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·F R AhmannS Rodney
Jan 1, 1980·Cancer Chemotherapy and Pharmacology·R T DorrH S Chen
Citations
Jun 26, 2013·Purinergic Signalling·Geoffrey Burnstock, Francesco Di Virgilio
Aug 12, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·P KornblithD Burholt
Aug 1, 2005·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Shin Myung KangJoo-Hang Kim
Oct 31, 2006·Leukemia & Lymphoma·Michael NerenbergAlan Saven
Apr 30, 2008·Cancer Investigation·Seung-Su HanSoon-Beom Kang
May 30, 2013·Acta Oncologica·Anne von HeidemanPeter Nygren
Aug 22, 2014·Journal of Translational Medicine·Jiandong WangChunxiao Zhou
Feb 3, 2009·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·Y B ChoH-K Chun
Jun 8, 2010·Neuropathology and Applied Neurobiology·T P DawsonC H G Davis
Feb 22, 2005·Gynecologic Oncology·K F TamH Y S Ngan
Sep 15, 2004·Cancer Letters·Chung-Wei FanErr-Cheng Chan
Apr 25, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Wen-Qing GeShi-Ying Zheng
Apr 27, 2017·Critical Reviews in Clinical Laboratory Sciences·Khalid El BairiSaid Afqir
Nov 24, 2007·The Journal of International Medical Research·S U WooB W Koo
May 4, 2010·Journal of Korean Medical Science·Jee Hyun KimYung-Jue Bang
Oct 18, 2014·Yonsei Medical Journal·Maria LeeSunghoon Kim
Jun 7, 2013·Journal of the Korean Surgical Society·Jina ChangByung-In Moon
Jul 25, 2009·Obstetrical & Gynecological Survey·Vanessa N HarryDavid E Parkin
Jun 5, 2003·Anti-cancer Drugs·Martina BreidenbachChristian M Kurbacher
Feb 6, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Lan Ying LiYoung Tae Kim
Jul 3, 2021·Medicina·Engin UlukayaKonstantinos Dimas